- Home
- MPX vs LRMR Comparison
MPX vs LRMR Comparison
Compare MPX & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- LRMR
- Stock Information
- Founded
- MPX 1965
- LRMR N/A
- Country
- MPX United States
- LRMR United States
- Employees
- MPX N/A
- LRMR N/A
- Industry
- MPX Marine Transportation
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- LRMR Health Care
- Exchange
- MPX Nasdaq
- LRMR Nasdaq
- Market Cap
- MPX 312.9M
- LRMR 309.8M
- IPO Year
- MPX N/A
- LRMR N/A
- Fundamental
- Price
- MPX $9.27
- LRMR $3.94
- Analyst Decision
- MPX
- LRMR Strong Buy
- Analyst Count
- MPX 0
- LRMR 8
- Target Price
- MPX N/A
- LRMR $17.88
- AVG Volume (30 Days)
- MPX 18.6K
- LRMR 1.4M
- Earning Date
- MPX 10-23-2025
- LRMR 10-29-2025
- Dividend Yield
- MPX 6.16%
- LRMR N/A
- EPS Growth
- MPX N/A
- LRMR N/A
- EPS
- MPX 0.40
- LRMR N/A
- Revenue
- MPX $224,368,000.00
- LRMR N/A
- Revenue This Year
- MPX $3.97
- LRMR N/A
- Revenue Next Year
- MPX $13.02
- LRMR N/A
- P/E Ratio
- MPX $22.73
- LRMR N/A
- Revenue Growth
- MPX N/A
- LRMR N/A
- 52 Week Low
- MPX $7.49
- LRMR $1.61
- 52 Week High
- MPX $10.32
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- MPX 60.71
- LRMR 56.01
- Support Level
- MPX $8.74
- LRMR $3.59
- Resistance Level
- MPX $9.12
- LRMR $4.08
- Average True Range (ATR)
- MPX 0.29
- LRMR 0.28
- MACD
- MPX 0.03
- LRMR -0.01
- Stochastic Oscillator
- MPX 100.00
- LRMR 67.42
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.